Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > New formulation delivers up to 2,708% more CBD into bloodstr

<< Previous

Bullboard Posts

Next >>

Comment by WakeUPPon May 20, 2021 1:55pm

108 Views

Post# 33241286

RE:RE:RE:New formulation delivers up to 2,708% more CBD into bloodstr

10 rats lol

thet really spent the money there

stock price back to $5s

but someone made a ton on the one day it went up

how do you get the results you want in a study? you do it with a very low sample size (inclduign with rats lol).

the market knows exactly what happened, regarldess of how many times lex posts utter nonsense on stockhouse

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market